LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New Imaging Technique Reduces Skin Tone Bias in Breast Cancer Detection

By LabMedica International staff writers
Posted on 19 Nov 2024
Print article
Image: Photoacoustic images of a splayed vessel structure underlying very light and dark skin tones (Photo courtesy of asquinha, Gubbi, and Bell, doi 10.1117/1.BIOS.2.1.012502)
Image: Photoacoustic images of a splayed vessel structure underlying very light and dark skin tones (Photo courtesy of asquinha, Gubbi, and Bell, doi 10.1117/1.BIOS.2.1.012502)

Breast cancer remains a significant global health issue, and early detection is key to successful treatment. Traditional imaging techniques like mammography often face challenges, particularly for women with dense breast tissue. Photoacoustic imaging, which uses a combination of light and sound to produce detailed images of breast tissue, presents a potential solution. However, recent research has identified a major issue: skin tone bias.

Researchers from Johns Hopkins University (Baltimore, MD, USA) conducted a study to assess how skin tone affects the visibility of breast cancer targets in photoacoustic imaging. Published in Biophotonics Discovery, the research evaluated three image reconstruction methods: fast Fourier transform (FFT)-based reconstruction, delay-and-sum (DAS) beamforming, and short-lag spatial coherence (SLSC) beamforming. The study involved simulations with various wavelengths (757, 800, and 1064 nm), target sizes (ranging from 0.5 to 3 mm), and skin tones (from very light to dark).

The findings revealed that traditional methods like FFT and DAS struggled to visualize small targets in darker skin tones, particularly at 757 and 800 nm wavelengths. Targets smaller than 3 mm were especially difficult to detect, with lower signal-to-noise ratios (SNR) and contrast-to-noise ratios (gCNR). In contrast, the 1064 nm wavelength showed notable improvements, particularly when paired with SLSC beamforming, enhancing the visibility of targets across all skin tones and providing clearer images with higher SNR and gCNR values.

The study findings offer promising implications for the future of breast cancer detection. By addressing the skin tone bias, photoacoustic imaging could become a more accurate and equitable tool for early diagnosis, benefiting women of all skin tones. The study highlights the importance of considering skin tone when designing next-generation imaging systems, ensuring more inclusive healthcare solutions.

“This work was motivated by a previously poor understanding of photoacoustic imaging performance under combined variations of small target sizes and darker skin tones,” said senior and corresponding author Muyinatu Bell. “Our results are enlightening, as we now have a better understanding of advanced photoacoustic imaging techniques and associated wavelengths necessary to detect small targets.”

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Immunofluorescence Analyzer
MPQuanti
New
Auto Clinical Chemistry Analyzer
cobas c 703

Print article

Channels

Molecular Diagnostics

view channel
Image: The experimental blood test accurately indicates severity and predicts potential recovery from spinal cord injury (Photo courtesy of 123RF)

Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury

The National Institutes of Health estimates that 18,000 individuals in the United States sustain spinal cord injuries (SCIs) annually, resulting in a staggering financial burden of over USD 9.... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more

Industry

view channel
Image: Tumor-associated macrophages visualized using the Multiomic LS Assay (Photo courtesy of ACD)

Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Sekisui Diagnostics UK Ltd.